Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Assets (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Other Non-Current Assets for 15 consecutive years, with $120754.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 46.47% year-over-year to $120754.0, compared with a TTM value of $120754.0 through Oct 2025, down 46.47%, and an annual FY2025 reading of $120754.0, down 46.47% over the prior year.
  • Other Non-Current Assets was $120754.0 for Q4 2025 at Pharma-Bio Serv, down from $225649.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $353407.0 in Q3 2021 and bottomed at $111665.0 in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $204543.3, with a median of $178299.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Assets plummeted 63.14% in 2023, then surged 102.06% in 2025.
  • Year by year, Other Non-Current Assets stood at $353354.0 in 2021, then crashed by 62.96% to $130874.0 in 2022, then decreased by 14.68% to $111665.0 in 2023, then skyrocketed by 102.03% to $225599.0 in 2024, then crashed by 46.47% to $120754.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for PBSV at $120754.0 in Q4 2025, $225649.0 in Q3 2025, and $225643.0 in Q2 2025.